| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |